Zasocitinib
CAS 2272904-53-5
Overview
Zasocitinib (formerly TAK-279) is an oral, highly selective, allosteric tyrosine kinase 2 (TYK2) inhibitor being developed by Takeda Pharmaceuticals for inflammatory conditions, including moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease
Anant Labs manufacture and furnish high quality Zasocitinib impurities for global markets. Our Zasocitinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS2272904-53-5
Mol. FormulaC23H24N8O3
Mol. Weight460.498 g/mol
IUPACN-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo-1-pyridin-2-yl-3-pyridinyl)amino]pyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCNC1=CC(=NC2=C(C=NN12)C(=O)N[C@@H]3CC[C@H]3OC)NC4=CC=CN(C4=O)C5=CC=CC=N5
InChIInChI=1S/C23H24N8O3/c1-24-20-12-18(27-16-6-5-11-30(23(16)33)19-7-3-4-10-25-19)29-21-14(13-26-31(20)21)22(32)28-15-8-9-17(15)34-2/h3-7,10-13,15,17,24H,8-9H2,1-2H3,(H,27,29)(H,28,32)/t15-,17-/m1/s1
InChI KeyBWINBHTTZLVXGT-NVXWUHKLSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
2272904-53-5N-((1R,2R)-2-Methoxycyclobutyl)-7-(methylamino)-5-((2-oxo-2H-[1,2'-bipyridin]-3-yl)amino)pyrazolo[1,5-a]pyrimidine-3-carboxamideN-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo[1(2H),2'-bipyridin]-3-yl)amino]-pyrazolo[1,5-a]pyrimidine-3-carboxamideN-((1R,2R)-2-methoxycyclobutyl)-7-(methylamino)-5-((2-oxo(1(2H),2'-bipyridin)-3-yl)amino)-pyrazolo(1,5-a)pyrimidine-3-carboxamideN-((1R,2R)-2-methoxycyclobutyl)-7-(methylamino)-5-((2-oxo-2H-(1,2'-bipyridin)-3-yl)amino)pyrazolo(1,5-a)pyrimidine-3-carboxamideRefChem:822799957-394-0960-464-3ZasocitinibNDI-034858
